Anti–RNA Polymerase II Antibodies in a US Cohort of Systemic Sclerosis Patients: Comment on the Article by Hamaguchi et al

Publisher： John Wiley & Sons Inc

E-ISSN： 2326-5205|67|9|2547-2548

ISSN： 2326-5191

Source： ARTHRITIS & RHEUMATOLOGY, Vol.67, Iss.9, 2015-09, pp. : 2547-2548

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Demographic and clinical features of systemic sclerosis patients with anti‐RNA polymerase III antibodies

By  

THE JOURNAL OF DERMATOLOGY, Vol. 42, Iss. 2, 2015-02 ,pp. : 189-192

John Wiley & Sons Inc

Access to resources Recommend Favorite

Anti–RNA Polymerase III Autoantibody–Positive Scleroderma as a Paraneoplastic Syndrome: Comment on the Article by Stojan et al

By  

ARTHRITIS CARE AND RESEARCH, Vol. 67, Iss. 3, 2015-03 ,pp. : 453-453

John Wiley & Sons Inc

Access to resources Recommend Favorite

Is the Measurement of Anti–PM‐1α Antibodies at Least as Important as That of Other Systemic Sclerosis–Specific Antibodies? Comment on the Article by D'Aoust et al

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 66, Iss. 11, 2014-11 ,pp. : 3248-3248

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical and Immunologic Predictors of Scleroderma Renal Crisis in Japanese Systemic Sclerosis Patients With Anti–RNA Polymerase III Autoantibodies

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 67, Iss. 4, 2015-04 ,pp. : 1045-1052

John Wiley & Sons Inc

Access to resources Recommend Favorite

Association of anti‐RNA polymerase III antibody and malignancy in Japanese patients with systemic sclerosis

By  

THE JOURNAL OF DERMATOLOGY, Vol. 42, Iss. 5, 2015-05 ,pp. : 524-527

John Wiley & Sons Inc

Access to resources Recommend Favorite